Compare Supra Boga Lestari Tbk. (RANC) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Supra Boga Lestari Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Supra Boga Lestari Tbk. trades at Rp545 (market cap 883.94B, 67.7K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Supra Boga Lestari Tbk. is far larger — about 8.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| RANC | SCPI | |
|---|---|---|
Market Cap | 883.94B | 104.4B |
Volume | 67.7K | — |
Lot | 677 | — |
Turnover | 36.07M | — |
Average Price | 532.74 | — |
Value | 36.07M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Supra Boga Lestari Tbk.
PT Supra Boga Lestari Tbk (the Company) was established in Indonesia based on Notarial Deed No. 34 of Suwarni Sukiman, S.H., dated May 28, 1997.
Read more on RANC →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
